[1] |
付晗,张川,孙立娟, 等. 糖尿病足复发感染病原菌及相关危险因素[J]. 中国老年学杂志,2014,24(2):6903-6905.
|
[2] |
Chen XW, Zheng LJ, Li WJ, et al. Pathogenic bacteria causing infections in diabetic foot patients[J]. Chin J Nosocomiol,2014,24(1):76-60.
|
[3] |
Hatipoglu M, Mutluoglu M, Uzun G et al. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review[J]. Eur J Clin Microbiol Infect Dis,2014,33(6):871-878.
|
[4] |
李兵. 温针灸辅助治疗糖尿病足患者的疗效及对血清中IGF-1和MMP-9的影响[J]. 中国老年学杂志,2013,33(1):164-165
|
[5] |
吴迪,张伟,田霖林, 等. 糖尿病足患者高压氧治疗感染病原菌及耐药性分析[J]. 中华医院感染学杂志,2014,24(15):3751-3738.
|
[6] |
Zhao YH, Li H, Fan HH, et al. Distribution and drug resistance of pathogenic bacteria in diabetic foot infection[J]. Chin J Nosocomiol,2014,24(7):1620-1622.
|
[7] |
王冬梅,苏文昭,于大勇, 等. 中西医结合治疗糖尿病足30例临床观察[J]. 中国临床医生,2013,41(2):61-62.
|
[8] |
Bakker K, Schaper NC. The development of global consensus guidelines on the management and prevention of the diabetic foot[J]. Diabetel Metab Res Rev,2013,28(1):116-118.
|
[9] |
Brechow A, Slesaczeck T, Münch D, et al. Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease[J]. Ther Adv Endocrinol Metab,2013,4(3):83-94.
|
[10] |
Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the U.S[J]. Diabetes Care,2013,26(6):1790-1795.
|
[11] |
Rezende KF, Ferraz MB, Malerbi DA, et al. Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country--a simulation of the current situation in Brazil[J]. Diabetic Medicine,2010,27(1):109-112.
|
[12] |
Santos ICRV, Sobreira CMM, Nunes ÉNDS, et al. The prevalence and factors associated with diabetic foot amputations[J]. Ciência & Saúde Coletiva,2013,18(10):3007-3014.
|
[13] |
Battum P Van, Schaper N, Prompers L, et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation[J]. Diabetic Medicine,2011,28(2):199-205.
|
[14] |
Pscherer S, Dippel FW, Lauterbach S, et al. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany[J]. Primary Care Diabetes,2012,6(3):241-246.
|
[15] |
Weck M, Slesaczeck T, Paetzold H, et al. Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates[J]. Cardiovascular Diabetology,2013,12(45):1203-1206.
|
[16] |
Olmen J Van, Marie KG, Christian D, et al. Content, participants and outcomes of three diabetes care programmes in three low and middle income countries[J]. Primary Care Diabetes,2014,12(8):126-128.
|
[17] |
Quddus MA, Uddin MJ. Evaluation of foot ulcers in diabetic patients[J]. Mymensingh Medical Journal,2013,22(3):527-532.
|
[18] |
Gemechu FW, Seemant F, Curley CA. Diabetic foot infections[J]. Am Fam Physician,2013,88(3):636-639.
|
[19] |
Lévigne D, Tobalem M, Modarressi A, et al. Hyperglycemia increases susceptibility to ischemic necrosis[J]. Bio Med Res Inter,2013,49(6):1206-1208.
|
[20] |
Kavitha KV, Tiwari S, Purandare VB, et al. Choice of wound care in diabetic foot ulcer: a practical approach[J]. World J Diabet,2014,5(4):546-556.
|
[21] |
Rottschaefer SM. No Effect of Wolbachia on Resistance to Intracellular Infection by Pathogenic Bacteria in Drosophila melanogaster[J]. PLoS One,2012,7(7):266.
|
[22] |
Erfurt-Berge C. Recent Developments in topical wound therapy: impact of antimicrobiological changes and rebalancing the wound milieu[J]. Bio Med Res Inter,2014,28(1):155-165.
|
[23] |
徐岩. 运用胰岛素外敷治疗糖尿病足60例的护理分析[J]. 贵阳中医学院学报,2013,34(1):211-213.
|
[24] |
Kloepfer KM, Lee WM, Pappas TE, et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations[J]. J Allergy Clin Immunol,2014,133(5):1301-1307. e3.
|
[25] |
Liu YJ, Hou JH, Yuan MY. Distribution of pathogenic bacteria causing diabetic foot infections[J]. Chin J Nosocomiol,2014,24(4):830-833.
|